Release 5 Ballot
TerminologyThis page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R5 R4B
| Biomedical Research and Regulation Work Group | Maturity Level: 1 | Trial Use | Use Context: Not yet ready for Production use, Not yet ready for Production use |
This is a value set defined by the FHIR project.
Summary
| Defining URL: | http://hl7.org/fhir/ValueSet/medicinal-product-contact-type |
| Version: | 5.0.0-ballot |
| Name: | ProductContactType |
| Title: | ProductContactType |
| Status: | draft |
| Definition: | Contact type for a Medicinal Product. |
| Committee: | Biomedical Research and Regulation Work Group |
| OID: | 2.16.840.1.113883.4.642.3.3027 (for OID based terminology systems) |
| Flags: | Experimental, Immutable |
This value set is used in the following places:
http://hl7.org/fhir/medicinal-product-contact-type
This expansion generated 07 Sep 2022
This value set contains 5 concepts
Expansion based on ProductContactType v5.0.0-ballot (CodeSystem)
| Code | System | Display | Definition |
| ProposedMAH | http://hl7.org/fhir/medicinal-product-contact-type | Proposed Marketing Authorisation Holder/Person | Proposed Marketing Authorisation Holder/Person |
| ProcedureContactDuring | http://hl7.org/fhir/medicinal-product-contact-type | Person/Company authorised for Communication during procedure | Person/Company authorised for Communication on behalf of the Applicant during the Procedure |
| ProcedureContactAfter | http://hl7.org/fhir/medicinal-product-contact-type | Person/Company authorised for Communication after procedure | Person/Company authorised for Communication between MAH and Authorities after Authorisation |
| QPPV | http://hl7.org/fhir/medicinal-product-contact-type | Qualified Person Responsible for Pharmacovigilance | Qualified Person Responsible for Pharmacovigilance |
| PVEnquiries | http://hl7.org/fhir/medicinal-product-contact-type | Pharmacovigilance Enquiry Information | Pharmacovigilance Enquiry Information |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-ballot generated on Wed, Sep 7, 2022 11:02+1000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4 |
Compare to R5 Draft |
|
Propose a change